Cargando…

Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions

BACKGROUND: Bilastine, a non-sedating H(1)-antihistamine, is indicated to treat the symptoms of allergic disorders (e.g. rhinoconjunctivitis and urticaria) in adults and adolescents and, more recently, in children. Following its marketing approval, many questions regarding the ideal use of bilastine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leceta, Amalia, García, Aintzane, Sologuren, Ander, Campo, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366504/ https://www.ncbi.nlm.nih.gov/pubmed/34457015 http://dx.doi.org/10.7573/dic.2021-5-1

Ejemplares similares

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
por: Lasseter, Kenneth C., et al.
Publicado: (2013)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

Application of a dual mechanistic approach to support bilastine dose selection for older adults
por: Kim, Chaejin, et al.
Publicado: (2021)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study
por: Coimbra, Jimena, et al.
Publicado: (2022)

Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
por: Verta, Roberta, et al.
Publicado: (2019)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

Green quality by design HPLC approach for the simultaneous determination of Bilastine and Montelukast
por: Roshdy, Aya, et al.
Publicado: (2023)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
por: Ochoa, Dolores, et al.
Publicado: (2021)

Effectiveness of bilastine and fexofenadine among allergic Rhinitis patients in Ranchi, Jharkhand, India
por: Kumari, Abha, et al.
Publicado: (2022)

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect
por: Pioro, Erik P.
Publicado: (2014)

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis
por: Singh Randhawa, Aranjit, et al.
Publicado: (2022)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study
por: Kuna, Piotr, et al.
Publicado: (2023)

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild‐to‐moderate asthma. The SKY study
por: Lavorini, Federico, et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
por: Togawa, Michinori, et al.
Publicado: (2016)

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
por: Viigimaa, Margus, et al.
Publicado: (2010)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
por: Shah, Bela, et al.
Publicado: (2022)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

Paediatric rheumatology update /
Publicado: (1990)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
por: De, Abhishek, et al.
Publicado: (2021)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Beta-decay of $^{20}$Mg
por: Piechaczek, A, et al.
Publicado: (1994)

Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk
por: Cho, Yun-Kyeong, et al.
Publicado: (2011)

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in Conjunctiva Up to 24 h Postadministration
por: Torrens, Inés, et al.
Publicado: (2022)

Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial
por: Dewan, Bhupesh, et al.
Publicado: (2011)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Suvorexant (Belsomra(®) Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
por: Asai, Yuko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nbalirbhkjm4je47asdnes8v9p